Hormonal Contraceptives Market Forecasts to 2030 – Global Analysis By Product Type (Injectable Birth Control, Oral Contraceptive Pills, Vaginal Rings, Emergency Contraceptive Pills, Transdermal Patches, Combined Oral Contraceptives, Implanted Contraceptiv

Hormonal Contraceptives Market Forecasts to 2030 – Global Analysis By Product Type (Injectable Birth Control, Oral Contraceptive Pills, Vaginal Rings, Emergency Contraceptive Pills, Transdermal Patches, Combined Oral Contraceptives, Implanted Contraceptives and Intrauterine), Hormone (Estrogens, Androgens, Gonadotropins, Progestogens, Antiandrogens and Other Hormones), Age Group, Gender, End User and By Geography


According to Stratistics MRC, the Global Hormonal Contraceptives Market is accounted for $18.3 billion in 2023 and is expected to reach $28.2 billion by 2030 growing at a CAGR of 6.3% during the forecast period. Birth control treatments that work on the endocrine system are called hormonal contraceptives. These techniques involve using hormones that women typically make, including progesterone and estrogen to stop ovulation and pregnancy. Hormonal contraception alters the uterus, decreasing the possibility of pregnancy. Hormonal contraceptives come in several forms, including skin-attached patches, pills, injections, arm implants, and intrauterine devices. These hormonal contraceptive methods are trustworthy and safe for preventing pregnancy. Over 99% of unwanted pregnancies are avoided when hormonal contraceptives are used.

According to the World Health Organization, modern contraception rose from 54% in 1990 to 57.4% in 2015 globally.

Market Dynamics:

Driver:

Rising global population

The world's population continues to grow, and this demographic trend has contributed to the increasing demand for effective birth control methods. Hormonal contraceptives have gained popularity due to their reversible nature, ease, and effectiveness in helping people control the size of their families and postpone or space out pregnancies. As individuals strive to achieve their desired family size and improve their socioeconomic conditions, access to effective contraception becomes crucial. These factors propel market demand.

Restraint:

Associated side effects

Potential drawbacks include thrush, or vaginal yeast infections, along with side effects like headaches, nausea, and sore breasts. In addition to causing mood swings and spotting in between periods, the hormones may lessen women's desire for sex. Additionally, there is a slight chance that blood clots (thrombosis) will form. Women who smoke, are extremely overweight, or have a family history of vascular disease are more likely to be at risk than women over 40. Therefore, these related drawbacks might hinder market expansion.

Opportunity:

Technological innovations

New and enhanced hormonal contraceptive methods have been made available as a result of advancements in pharmaceutical research and development. Low-dose formulations, long-acting reversible contraceptives (LARCs), including hormonal IUDs and contraceptive implants, and cutting-edge delivery methods like Trans dermal patches are some of them. Technological innovations have increased consumer choice and promoted market expansion.

Threat:

Regulatory policies and restrictions

The market may be severely impacted by laws and regulations limiting the supply and use of hormonal contraceptives. Hormonal contraception use is restricted or hindered in many countries due to strict rules or cultural and religious beliefs. However, these limitations may impede the expansion of the market and restrict the availability of hormonal contraceptives to those who require them.

Covid-19 Impact

Due to the drop in family planning and the necessity to avoid unwanted pregnancies during the pandemic, COVID-19 has had a little negative overall influence on the market for hormonal contraceptives. These contraceptives are mostly used in family planning. Clinic closures, appointment cancellations, and a shortage of healthcare practitioners may have restricted access to contraception, particularly hormonal contraceptives. This restriction on access might have led to a decline in the market for hormonal contraceptives or an increase in the use of less potent forms of birth control.

The oral contraceptive pills segment is expected to be the largest during the forecast period

The oral contraceptive pills segment is estimated to hold the largest share. OCPs have been available for a number of decades and are among the most popular types of hormonal contraceptives. Oral contraceptive pills are a popular option for people looking for dependable contraception because they are quite effective when used appropriately and consistently. They function by inhibiting ovulation, thickening cervical mucus, and weakening the uterine lining, all of which block sperm from getting to the egg. Oral contraceptive pills are taken daily; most formulations require 21 days of active pills, followed by a week of hormone-free or placebo pills.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to have lucrative growth during the forecast period. The main factors contributing to segmental growth are the expanding unmet need for these hormonal forms of contraception, women's preference for irreversible contraception in emerging economies, the introduction of innovative intrauterine devices by corporations like Allergen and Bayer AG, and the development of multispecialty hospitals. Furthermore, due to the increasing investment in hospital pharmacy improvement, particularly in developing nations.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to factors like the high rate of hormonal contraception uptake, the strong presence of industry players in the area, and superior healthcare infrastructure. Hormonal contraceptives have a well-established organization in North America. The region benefits from a high level of acceptance and knowledge of contraceptive methods and reasonably simple access to hormonal contraceptives via pharmacies and healthcare practitioners. A variety of contraceptive methods, such as oral tablets, patches, injections, and intrauterine devices (IUDs), are available in the North American market.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period. Hormonal contraception sales are thriving and varied across Europe. Different European nations have different cultural and legal conventions around contraception, which causes variations in the availability of the product, prescription requirements, and patterns of use. Major pharmaceutical businesses that produce and market hormonal contraceptives are also heavily represented in the region. A variety of contraceptive techniques, such as oral tablets, patches, rings, and implants, are usually available in European countries.

Key players in the market

Some of the key players in the Hormonal Contraceptives Market include Bayer Healthcare Pharmaceuticals, Amgen, Cipla Limited, Novartis AG, Glenmark Pharmaceuticals, Pfizer, Inc., Lupin Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., Piramal Healthcare Limited, Teva Pharmaceutical Industries, Abbvie Inc., Organon group of companies, Agile Therapeutics, Janssen Pharmaceutical, Inc., Pregna International Limited, Pantarhei Bioscience and Mayne Pharma Group Limited.

Key Developments:

In May 2021, Pantarhei Bioscience made an announcement that the company got the approval for new oral contraceptive Estelle from the European Commission. With the approval of Estelle, contraceptive can be marketed in all the European states.

In April 2021, Mayne Pharma Group Limited and Mithra Pharmaceuticals announced the approval by U.S Food and Drug Administration (FDA) for oral contraceptive NEXTSTELLIS. It is the only contraceptive pill containing estetrol, which is produced from a plant source.

Product Types Covered:
• Injectable Birth Control
• Oral Contraceptive Pills
• Vaginal Rings
• Emergency Contraceptive Pills
• Transdermal Patches
• Combined Oral Contraceptives
• Implanted Contraceptives
• Intrauterine

Hormones Covered:
• Estrogens
• Androgens
• Gonadotropins
• Progestogens
• Antiandrogens
• Other Hormones

Age Groups Covered:
• 15 To 24 Years
• 25 To 34 Years
• 35 To 44 Years
• Above 44 Years

Genders Covered:
• Female
• Male

End Users Covered:
• Household
• Hospitals
• Clinics
• Retail Pharmacies
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Hormonal Contraceptives Market, By Product Type
5.1 Introduction
5.2 Injectable Birth Control
5.3 Oral Contraceptive Pills
5.4 Vaginal Rings
5.5 Emergency Contraceptive Pills
5.6 Transdermal Patches
5.7 Combined Oral Contraceptives
5.8 Implanted Contraceptives
5.9 Intrauterine
6 Global Hormonal Contraceptives Market, By Hormone
6.1 Introduction
6.2 Estrogens
6.3 Androgens
6.4 Gonadotropins
6.5 Progestogens
6.6 Antiandrogens
6.7 Other Hormones
7 Global Hormonal Contraceptives Market, By Age Group
7.1 Introduction
7.2 15 To 24 Years
7.3 25 To 34 Years
7.4 35 To 44 Years
7.5 Above 44 Years
8 Global Hormonal Contraceptives Market, By Gender
8.1 Introduction
8.2 Female
8.3 Male
9 Global Hormonal Contraceptives Market, By End User
9.1 Introduction
9.2 Household
9.3 Hospitals
9.4 Clinics
9.5 Retail Pharmacies
9.6 Other End Users
10 Global Hormonal Contraceptives Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Bayer Healthcare Pharmaceuticals
12.2 Amgen
12.3 Cipla Limited
12.4 Novartis AG
12.5 Glenmark Pharmaceuticals
12.6 Pfizer, Inc.
12.7 Lupin Pharmaceuticals, Inc.
12.8 Sun Pharmaceutical Industries Ltd.
12.9 Piramal Healthcare Limited
12.10 Teva Pharmaceutical Industries
12.11 Abbvie Inc.
12.12 Organon group of companies.
12.13 Agile Therapeutics
12.14 Janssen Pharmaceutical, Inc.
12.15 Pregna International Limited
12.16 Pantarhei Bioscience
12.17 Mayne Pharma Group Limited
List of Tables
Table 1 Global Hormonal Contraceptives Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Hormonal Contraceptives Market Outlook, By Product Type (2021-2030) ($MN)
Table 3 Global Hormonal Contraceptives Market Outlook, By Injectable Birth Control (2021-2030) ($MN)
Table 4 Global Hormonal Contraceptives Market Outlook, By Oral Contraceptive Pills (2021-2030) ($MN)
Table 5 Global Hormonal Contraceptives Market Outlook, By Vaginal Rings (2021-2030) ($MN)
Table 6 Global Hormonal Contraceptives Market Outlook, By Emergency Contraceptive Pills (2021-2030) ($MN)
Table 7 Global Hormonal Contraceptives Market Outlook, By Transdermal Patches (2021-2030) ($MN)
Table 8 Global Hormonal Contraceptives Market Outlook, By Combined Oral Contraceptives (2021-2030) ($MN)
Table 9 Global Hormonal Contraceptives Market Outlook, By Implanted Contraceptives (2021-2030) ($MN)
Table 10 Global Hormonal Contraceptives Market Outlook, By Intrauterine (2021-2030) ($MN)
Table 11 Global Hormonal Contraceptives Market Outlook, By Hormone (2021-2030) ($MN)
Table 12 Global Hormonal Contraceptives Market Outlook, By Estrogens (2021-2030) ($MN)
Table 13 Global Hormonal Contraceptives Market Outlook, By Androgens (2021-2030) ($MN)
Table 14 Global Hormonal Contraceptives Market Outlook, By Gonadotropins (2021-2030) ($MN)
Table 15 Global Hormonal Contraceptives Market Outlook, By Progestogens (2021-2030) ($MN)
Table 16 Global Hormonal Contraceptives Market Outlook, By Antiandrogens (2021-2030) ($MN)
Table 17 Global Hormonal Contraceptives Market Outlook, By Other Hormones (2021-2030) ($MN)
Table 18 Global Hormonal Contraceptives Market Outlook, By Age Group (2021-2030) ($MN)
Table 19 Global Hormonal Contraceptives Market Outlook, By 15 To 24 Years (2021-2030) ($MN)
Table 20 Global Hormonal Contraceptives Market Outlook, By 25 To 34 Years (2021-2030) ($MN)
Table 21 Global Hormonal Contraceptives Market Outlook, By 35 To 44 Years (2021-2030) ($MN)
Table 22 Global Hormonal Contraceptives Market Outlook, By Above 44 Years (2021-2030) ($MN)
Table 23 Global Hormonal Contraceptives Market Outlook, By Gender (2021-2030) ($MN)
Table 24 Global Hormonal Contraceptives Market Outlook, By Female (2021-2030) ($MN)
Table 25 Global Hormonal Contraceptives Market Outlook, By Male (2021-2030) ($MN)
Table 26 Global Hormonal Contraceptives Market Outlook, By End User (2021-2030) ($MN)
Table 27 Global Hormonal Contraceptives Market Outlook, By Household (2021-2030) ($MN)
Table 28 Global Hormonal Contraceptives Market Outlook, By Hospitals (2021-2030) ($MN)
Table 29 Global Hormonal Contraceptives Market Outlook, By Clinics (2021-2030) ($MN)
Table 30 Global Hormonal Contraceptives Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 31 Global Hormonal Contraceptives Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings